Celgene CEO: New therapies for a certain type of cancer boost survival rates 10-fold
December 11, 2017 at 13:48 PM EST
Celgene and Bluebird Bio find results in treating patients with multiple myeloma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|